Patient Adherence Program
Program overview
This sponsored program aims to provide education and support to patients prescribed Lumigan or Lumigan PF eye drops for the treatment of glaucoma.
The program consists of a series of 12 messages delivered over 6 months, with information and topics focused on the quality use of medicines and improving medication adherence and treatment outcomes for patients.
When?
This program launched 11 December 2023.
For which patients?
Messages will be delivered via the app/email or SMS to patients currently prescribed Lumigan or Lumigan PF eye drops.

© 2026 MedAdvisor International Pty Ltd